Clinical TrialsSearch results
Number of results: 553
Other
- LIVES Study Extention
- hypercholesterolemia
- LIVES Study Extension advisory committee
- 2007-09-18
Other
- Mesorectal excision with lateral lymph node dissection versus without lateral lymph node dissection for clinical stage II, III lower rectal cancer(JCOG0212)
- Stage II, III lower rectal cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-01
Other
- MIRACLE-ICD outcome measured in Japanese indication
- Congestive Heart Failure, Ventricular Tachyarrhythmia.
- Medtronic Japan, Co., Ltd.
- 2007-02-01
Other
- MK-3475A SC vs pembrolizumab IV, administered with chemotherapy, in treatment-naive metastatic NSCLC
- Metastatic Non-small Cell Lung Cancer
- Koh Yasuhiro
- 2023-04-22
Other
- MK-4280A Versus Standard of Care in Previously Treated Metastatic PD-L1 positive Colorectal Cancer
- Previously treated metastatic PD-L1 positive colorectal cancer
- Shimoyama Ryo
- 2021-12-13
Other
- Multi-center clinical trial for diagnostic value of sentinel node biopsy to detect lymph node metastasis in gastric cancer
- Early gastric cancer
- Japanese Society for sentinel node navigation surgery
- 2006-09-01
Other
- Multi-Center Phase II Study on Efficacy of High-Slip Skin Care Pad for Hand-Foot Skin Reaction Caused by Sorafenib in Patients with Renal Cell Carcinoma
- Renal cell carcinoma
- Japanese Society of Renal Cancer (JSRC)
- 2009-05-29
Other
- Multi-centric randomized open-label comparative study for influence of bisphosphonate on fracture healing in patients with spinal compression fractures or femoral neck fractures
- Osteoporotic spinal compression fractures and femoral neck fractures
- Department of Orthopaedic Surgery, Dokkyo Medical University Koshigaya Hospital
- 2007-10-01
Other
- Multi-institute randomized study of natural type interferon alpha for patients with renal cell carcinoma after radical nephrectomy
- Renal cell carcinoma
- TRAIn-Alpha study group
- 2005-09-30
Other
- Multi-institutional phase II study of concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for locally advanced uterine cervical cancer.
- Locally advanced cervical cancer
- Japanese Gynecologic Oncology Group
- 2008-02-19